Cibc World Market Inc. decreased its position in The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 34.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 924 shares of the medical device company’s stock after selling 486 shares during the quarter. Cibc World Market Inc.’s holdings in Cooper Companies were worth $289,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently added to or reduced their stakes in the company. Trust Co. of Vermont acquired a new position in Cooper Companies in the 2nd quarter valued at about $27,000. Parkside Financial Bank & Trust increased its stake in shares of Cooper Companies by 65.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the medical device company’s stock valued at $30,000 after acquiring an additional 38 shares during the last quarter. Clear Street Markets LLC increased its stake in shares of Cooper Companies by 410.0% during the 2nd quarter. Clear Street Markets LLC now owns 102 shares of the medical device company’s stock valued at $32,000 after acquiring an additional 82 shares during the last quarter. Ellevest Inc. increased its stake in shares of Cooper Companies by 82.4% during the 2nd quarter. Ellevest Inc. now owns 124 shares of the medical device company’s stock valued at $39,000 after acquiring an additional 56 shares during the last quarter. Finally, Capital Advisors Ltd. LLC increased its stake in shares of Cooper Companies by 223.1% during the 1st quarter. Capital Advisors Ltd. LLC now owns 126 shares of the medical device company’s stock valued at $53,000 after acquiring an additional 87 shares during the last quarter. Institutional investors and hedge funds own 97.09% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on COO shares. Jefferies Financial Group downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating and dropped their price objective for the company from $400.00 to $295.00 in a research note on Tuesday, October 11th. Piper Sandler dropped their price objective on shares of Cooper Companies from $375.00 to $355.00 and set an “overweight” rating for the company in a research note on Thursday, November 3rd. StockNews.com began coverage on shares of Cooper Companies in a research note on Wednesday, October 12th. They set a “hold” rating for the company. Citigroup decreased their target price on Cooper Companies from $350.00 to $348.00 in a report on Wednesday, October 5th. Finally, Wells Fargo & Company decreased their target price on Cooper Companies from $370.00 to $365.00 and set an “overweight” rating for the company in a report on Thursday, September 1st. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $391.22.
Cooper Companies Stock Performance
Cooper Companies (NYSE:COO – Get Rating) last announced its earnings results on Wednesday, August 31st. The medical device company reported $3.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.20 by ($0.01). Cooper Companies had a net margin of 13.38% and a return on equity of 9.22%. The business had revenue of $843.40 million during the quarter, compared to analyst estimates of $830.22 million. During the same period in the previous year, the company earned $3.41 earnings per share. The business’s revenue for the quarter was up 10.5% on a year-over-year basis. Analysts forecast that The Cooper Companies, Inc. will post 12.77 EPS for the current fiscal year.
Cooper Companies Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
- Get a free copy of the StockNews.com research report on Cooper Companies (COO)
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Institutional Support for Analog Devices Remains High
- Microsoft Shares: Is it Time to Back Up the Truck?
- Is the 60/40 Portfolio Mix Still in Vogue?
- Three CBD Stocks to Dominate a Budding Industry
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.